反应详情

The title compound was prepared according to the procedure described in Example 1 using 2-(6-bromopyridin-2-yl)-N-(1-methyl-1-H-pyrazol-4-yl)acetamide (217 mg, 0.74 mmol) and 2-amino-5-[2,6-difluoro-4-(1-hydroxy-1-methylethyl)phenyl]thiophene-3-carboxamide (230 mg, 0.74 mmol) as starting materials.